[1]
“Comparative Analysis for Reduction in A1c in Dapagliflozin Versus Glimepiride Monotherapy in Non-Obese Type 2 Diabetic Patients”, mfm, vol. 32, no. 6, Jul. 2021, Accessed: Oct. 13, 2026. [Online]. Available: http://medicalforummonthly.com/index.php/mfm/article/view/1680